Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (9879)

Showing 12 of 9879 View All
Showing 254 of 824 pages

PPC Report to Board pdf

www.gavi.orgPROGRAMME AND POLICY
COMMITTEE CHAIR REPORT
Reach every childBOARD MEETING
Richard Sezibera
29 - 30 November 2017 , Vientiane, Lao PDR
Annex A
PPC Meeting, 26 - 27 October 2017
? Discussion, Information and Guidance Items
? CEO Update and Update on Implementation of Gavi?s Strategy
? Partners? Engagement Framework
? Alliance Update on Country Programmes
? Polio Transition Planning
? Risk & Assurance Report
? Update on Key Recommendations of the Independent Review Committee and High
Level Review Panel
2 Board meeting
29 - 30 November 2017
Annex A

IFFIm Report Board pdf

1



Board -2017 -Mtg -3-IFFIm Chair Report

Section A: Introduction
? This report provides the Board with an overview of the activities of the
International Finance Facility for Immunisation ( IFFIm) since the last Board
meeting in June 2017 .
? IFFIm continues to be a valuable tool for Gavi and its financial position
remains st rong.
? On 9 November, IFFIm successfully issued a US$ 300 million floating rate
benchmark bond issuance. The bond was oversubscribed and placed with
investors w orld wide.
? IFFIm Vaccine B onds helped pioneer socially responsible investing , and
growth in the S RI sector has gai ned traction in the past years. The Social
Bond Principles (?SBP?) , adopted in June 2017, recommend a clear process
and disclosure for issuers, investors and banks which emphasises
transparency, accuracy and integrity of information.
? IF FIm is well -aligned with the SPB allowing Board members it to re -connect
with existing investors and reach out to new ones through roadshows and
financial conferences.
? The IFFIm Board plans on adopting a diversity statement at its December
Board meeting. Beginning in 2018, the Board will work to develo p an
updated communications strategy and begin recruitment for two board
seats.
? Significant progress has been made in developing potential additional roles
for IFFIm to support Gavi?s strategic goals.
? At an IFFIm Donors? meeting on 12 June, IFFIm received feedback on the
proposed roles:
o Financial commitments for market shaping: designated as a priority
and development continues.
o Supporting CCEOP: work will continue on the development of this
role in alignment with CCEOP progress and needs while ensuring
coordination with the HSIS programme.
SUBJECT : IFFIm Chair Report
Agenda item: 11
Category: For Information
Report to the Gavi Board
29 -30 November 2017

Country Programmes strategic issues pdf

1



Board -2017 -Mtg -3-Doc 13

Section A: Introduction
? Based on the discussions at the Programme and Policy Committee (PPC)
in October, this paper provides an update to the Board on channelling
funding away from and back to government systems in the context of
ensuring programmatic sustainability and country o wnership.

? Annex A provides an update on the implementation of the Policy on
Fragility, Emergencies and Refugees (approved by the Board in June 2017).
The Operational Guideline (OG) that operationalises this Policy was
presented to the PPC (Appendix 6 to t he October 2017 Alliance update on
Country Programmes). During the development of this OG, relevant
stakeholders, including the CSO community, were consulted, and their
feedback has been reflected in the final document. The issues raised by the
Board at it s June meeting have all been clarified in the OG. The PPC also
reviewed measures that the Alliance will further explore to improve the
planning and implementation of campaigns and Supplementary
Immunisation Activities (SIAs) with a view to strengthening ro utine
immunisation (RI) efforts (see October 2017 Alliance update on Country
Programmes) .1 An update on the Secretariat?s thinking on the sustainability
tracers was also presented to the PPC (see Annex A to the October 2017
Alliance update on Country Progr ammes).
Section B: Alliance Update on Country Programmes
1. Channelling funds away from and back to government systems
1.1 In June 2017 the Board discussed that Gavi is increasingly channelling
funding through partners and other agents as a risk management measure,
which is not always conducive to the timeliness and predictability of funding
nor always easily reconcilable with the principles of country ownership and
sustainability. Since the last Board meeting the trend of channelling funding
away from government systems has further increased with a number of
additional grants being transitioned ? in part or in full ? away from funding

1 The Board has identified frequent or unplanned mass campaigns as one of the top 15 risks facing
the Alliance. See the 2017 updated Board risk appetite statement.
SUBJECT : COUNTRY PROGRAMMES: STRATEGIC ISSUES
Agenda item: 13
Category: For Information
Report to the Board
29 -30 November 2017

Accelerated Vaccine Introduction Project review: final report

Lessons learnt from the Accelerated Vaccine Introduction (AVI) Project.

HPV workplan [Russian]

HPV Regional Profile

2021-2025 Gavi Investment Opportunity - Executive Summary

The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.

2021-2025 Gavi Investment Opportunity

The 2021-2025 Investment Opportunity highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet. 

Download: English | French | Japanese | Arabic

Subscribe to our newsletter